Obesity, metabolic complications and the menopause: An opportunity for prevention

Climacteric

Volumn 13, Issue 3, 2010, Pages 203-209

  Teede, H J ^a,b,c   Lombard, C ^a,b   Deeks, A A ^a  

^a Jean Hailes Foundation for Women's Health   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c Diabetes Unit   (Australia)

Author keywords

Cardiovascular disease; Diabetes; Menopause; Metabolic; Obesity; Risk

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ESTROGEN; GESTAGEN; METFORMIN;

ACCURACY; CARDIOVASCULAR DISEASE; CHRONIC DISEASE; HEALTH EDUCATION; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; MENOPAUSE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIAL PSYCHOLOGY; WEIGHT GAIN; WELLBEING;

BODY MASS INDEX; CHRONIC DISEASE; ESTROGENS; FEMALE; HUMANS; INCIDENCE; INSULIN RESISTANCE; MENOPAUSE; METABOLIC SYNDROME X; OBESITY; PATIENT EDUCATION AS TOPIC; PREVALENCE;

EID: 77951801347     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697130903296909     Document Type: Review

References (52)

1. World Health Organization. Obesity - Preventing and Managing the Global Epidemic: Report of a WHO Expert Committee. Geneva: World Health Organization, 1998
2. Benjamin SM, Valdez R, Geiss LS, Rolka DB, Venkat Narayan KM. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care 2003;26:645-649
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295:1549-1555
4. Ausdiab 2005 follow up Study Report available at http:// www.diabetes.com.au/pdf/AUSDIAB-Report-Final.pdf
5. Brown W, Byles J, Carrigan G, et al. Trends in women's health: Results from the ALSWH - priority conditions, risk factors and health behaviours. Report prepared for The Australian Government Department of Health & Agèing 2006. Available at http://www. alswh.org.au/Reports/OtherReportsPDF/ MajorReportAOct 2006.pdf
6. Consensus Development Conference on Insulin Resistance. American Diabetes Association. Diabetes Care 1998;21: 310-314
7. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84:4006-4011
8. Balkau B, Charles MA, Drivsholm T, et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002;28:364-376
9. Ciampelli M, Leoni F, Cucinelli F, et al. Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 2005;90:1398-1406
10. Hutchison S, Zoungas S, Teede HJ. Insulin levels, insulin resistance and the use of metformin in polycystic ovary syndrome. Med J Aust 2007;186:268-269
11. Cobin RH. Polycystic ovarian syndrome and insulin resistance: implications for estrogen use in premenopausal and postmenopausal women. Metab Syndr Relat Disord 2005;3:259-269
12. Pasquali R, Gambineri A. Polycystic ovary syndrome: a multifaceted disease from adolescence to adult age. Ann NY Acad Sci 2006;1092:158-174
13. Teede H, Zoungas S, Deeks A, Farrell E, Moran L, Vollenhaven B. CHECK Independent Learning Program: Polycystic Ovarian Syndrome. Royal Australian College of General Practitioners, March 2008, Unit 432
14. Deeks A, Zoungas S, Teede H. Risk perception in women: a focus on menopause. Menopause 2008;15:304-309
15. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-1543
16. Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynecol Res 2008;34:776-783
17. Adderly-Kelly B, Williams-Stephens E. The relationship between obesity and breast cancer. ABNF J 2003;14:61-65
18. Steiner E, Klubert D, Knuston D. Assessing breast cancer risk in women. Am Fam Physician 2008;78:1361-1366
19. Ferrara CM, Lynch NA, Nicklas BJ, Ryan AS, Berman DM. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-4170
20. Carr MC. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-2411
21. Jones ME, Boon WC, Proietto J, Simpson ER. Of mice and men: the evolving phenotype of aromatase deficiency. Trends Endocrinol Metab 2006;17:55-64
22. Toth MJ, Tchernof A, Sites CK, Poehlman ET. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 2000;24:226-231
23. Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995;123:673-675
24. Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dualenergy x-ray absorptiometry in vivo. Am J Clin Nutr 1993;57:605-608
25. Pedersen SB, Bruun JM, Kristensen K, Richelsen B. Regulation of UCP1, UCP2, and UCP3 mRNA expression in brown adipose tissue, white adipose tissue, and skeletal muscle in rats by estrogen. Biochem Biophys Res Commun 2001;288:191-197
26. Roy EJ, Wade GN. Role of estrogens in androgen-induced spontaneous activity in male rats. J Comp Physiol Psychol 1975;89:573-579
27. Heine PA, Taylor JA, Iwamoto GA, Lubahn DB, Cooke PS. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 2000;97:12729-12734
28. Ravussin E, Lillioja S, Knowler WC, et al. Reduced rate of energy expenditure as a risk factor for body-weight gain. N Engl J Med 1988;318:467-472
29. Misso M, Jang C, Adams J, et al. Differential expression of factors involved in fat metabolism with age and the menopausal transition. Maturitas 2005;51: 299-306
30. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Q J Med 1992;85:889-896
31. Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atherosclerosis 1995;118:123-133
32. Lynch NA, Nicklas BJ, Berman DM, Dennis KE, Goldberg AP. Reductions in visceral fat during weight loss and walking are associated with improvements in VO(2 max). J Appl Physiol 2001;90:99-104
33. DeNino WF, Tchernof A, Dionne IJ, et al. Contribution of abdominal adiposity to age-related differences in insulin sensitivity and plasma lipids in healthy nonobese women. Diabetes Care 2001;24:925-932
34. Guthrie JR, Ball M, Dudley EC, et al. Impaired fasting glycaemia in middle-aged women: a prospective study. Int J Obes Relat Metab Disord 2001;25:646-651
35. Jones GL, Sutton A. Quality of life in obese postmenopausal women. Menopause Int 2008;14:26-32
36. Wadden TA, Butryn ML, Sarwer DB, et al. Comparison of psychosocial status in treatment-seeking women with class III vs. class I-II obesity. Obesity 2006;14(Suppl 2):90-8S
37. Bradshaw A, Katzer L, Horwath CC, et al. A randomised trial of three non-dieting programs for overweight women. Asia Pac J Clin Nutr 2004;13(Suppl):S43
38. Teixeira PJ, Going SB, Houtkeeper LB, et al. Pretreatment predictors of attrition and successful weight management in women. Int J Obes Relat Metab Disord 2004;28:1124-1133
39. Knowler W, Barrett Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
40. Lemmens V, Oenema A, Klepp KI, Henriksen HB, Brug J. A systematic review of the evidence regarding efficacy of obesity prevention interventions among adults. Obesity Rev 2008;9:446-455
41. Lombard CB, Deeks AA, Ball K, Jolley D, Teede HJ. A systematic review of interventions aimed at prevention of weight gain in adults. Public Health Nutr 2009 Aug 4. Epub ahead of print
42. Riddell LJ, Inman V. Body weight and weight loss: are health messages reaching their target. Asia Pac J Clin Nutr 2007;16:683-687
43. Lombard C, Deeks A, Ball K, Jolley D, Teede T. Weight, physical activity and dietary behaviour change in a population of young mothers: short term results of the HeLP-her cluster randomized controlled trial. Nutr J 2009;8:17
44. Mosca L, Ferris A, Fabunmi R, Robertson RM. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 2004;109: 573-579
45. Teede HJ, Zoungas S, Hutchison S. The management of insulin resistance in PCOS. Trends Endocrinol Metab 2007;18:273-279
46. Lobo RA. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18
47. Lobo RA. Menopause and stroke and the effects of hormonal therapy. Climacteric 2007;10(Suppl 2): 27-31
48. Augoulea A, Mastorakos G, Lambrinoudaki I, Christodoulakos G, Creatsas G. Role of postmenopausal hormone replacement therapy on body fat gain and leptin levels. Gynecol Endocrinol 2005;20:227-235
49. Salpeter SR, Walsh JM, Ormisotn TM, Greyber E, Buckley NS, Salpeter EE. Meta-analysis: effect of hormonereplacement therapy on components of the metabolic syndrome in postmenopausal women. Diabetes Obes Metab 2006;8:538-554
50. Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy. Am J Med 2005;118(Suppl 12B):148-154
51. Cate Kongnyuy EJ, Norman RJ, Flight IHK, Rees MC. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution. Cochrane Database of Systematic Reviews 1999, Issue 3. Art. No.: CD001018. DOI: 10.1002/14651858.CD001018. Updated 2005
52. Cameron AJ, Welborn TA, Zimmet PZ, et al. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Med J Aust 2003;178:427-432